DC Funds’s TScan Therapeutics TCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $914K | Hold |
630,000
| – | – | 42.43% | 1 |
|
|
2025
Q1 | $869K | Hold |
630,000
| – | – | 42.07% | 1 |
|
|
2024
Q4 | $1.92M | Hold |
630,000
| – | – | 53.75% | 1 |
|
|
2024
Q3 | $3.14M | Hold |
630,000
| – | – | 60.91% | 1 |
|
|
2024
Q2 | $3.69M | Hold |
630,000
| – | – | 61.2% | 1 |
|
|
2024
Q1 | $5M | Hold |
630,000
| – | – | 48.34% | 1 |
|
|
2023
Q4 | $3.67M | Hold |
630,000
| – | – | 44.16% | 1 |
|
|
2023
Q3 | $1.61M | Hold |
630,000
| – | – | 33.2% | 2 |
|
|
2023
Q2 | $1.58M | Hold |
630,000
| – | – | 33.55% | 2 |
|
|
2023
Q1 | $1.32M | Hold |
630,000
| – | – | 30.82% | 3 |
|
|
2022
Q4 | $977K | Hold |
630,000
| – | – | 26.44% | 3 |
|
|
2022
Q3 | $1.92M | Hold |
630,000
| – | – | 28.97% | 3 |
|
|
2022
Q2 | $1.98M | Hold |
630,000
| – | – | 27.33% | 3 |
|
|
2022
Q1 | $1.76M | Hold |
630,000
| – | – | 22.92% | 3 |
|
|
2021
Q4 | $2.84M | Hold |
630,000
| – | – | 16.79% | 3 |
|
|
2021
Q3 | $5.25M | Buy |
+630,000
| New | +$5.25M | 20.63% | 3 |
|